Distribution of human beta-defensin polymorphisms in various control and cystic fibrosis populations
Abstract
Human beta defensins contribute to the first line of defense against infection of the lung. Polymorphisins in these genes are therefore potential modifiers of the severity of lung disease in cystic fibrosis.
Polymorphisms were sought in the human beta-defensin genes DEFB1, DEFB4, DEFB103A, and DEFB104 in healthy individuals and cystic fibrosis (CF) patients living in various European countries. DEFB1, DEFB4, and DEFB104 were very polyinorphic, but DEFB103A was not.
Within Europe, differences between control populations were found for some of the frequent polymorphisms in DEFB1, with significant differences between South-Italian and Czech populations. Moreover, frequent polymorphisms located in DEFB4 and DEFB104 were not in Hardy Weinberg equilibrium in all populations studied, while those in DEFB1 were in Hardy Weinberg equilibrium.
Sequencing of a nionochromosomal chromosome 8 mouse-human hybrid cell line revealed signals for multiple alleles for some loci in DFF84 and DEFB104, but not for DEFB1. This indicated that more than one DEFB4 and DEFB104 gene was present on this chromosome 8, in agreement with recent findings that DEFB4 and DEFB104 are part of a repeat region.
Individual DEFB4 and DEFB104 PCR amplification products of various samples were cloned and sequenced. The results showed that one DNA sample could contain more than two haplotypes, indicating that the various repeats on one chromosome were not identical.
Given the higher complexity found in the genomic organization of the DEFB4 and DEFB104 genes, association studies with CF lung disease severity were performed only for frequent polymorphisins located in DEFB1. No association with the age of first infection by Pseudomonas aeruainosa or with the FEV1 percentage at the age of 11-13 years could be found.